About VeloGene

Marketing Activities

image
ASGCT 2026 Concludes Successfully | TurboMice™ Technology Links Global CGT Innovation
From May 11to 15, 2026, the 29th Annual Meetingof the American Societyof Gene + Cell Therapy (ASGCT)​...
image
On-Site at the Conference | MingCeler Exhibits TurboMice™ at BIOCHINA 2026, Accelerating New Drug R&D with Innovative Technology​
The 11th E-Bioindustry Exhibition (BIOCHINA 2026) was successfully held at Suzhou International Expo...
image
Conference Spotlight: TurboMice™ Tetraploid Complementation Technology Accelerates New Drug R&D
From May 8th to 10th, the 28th China Beijing International High-tech Expo (CHITEC) was successfully held...
ASGCT
Invitation | MingCeler at ASGCT 2026 Annual Meeting in Boston & Online
The 2026 ASGCT Annual Meeting will grandly kick off from May 11th to 15th at the Boston Convention and...
image
Invitation | Join Us at the 28th Beijing International High-tech Expo
The 28th Beijing International High-tech Expo (HI-tech Expo) will grandly open from May 8th to 10th at...
image
Invitation to Attend | MingCeler Invites You to Join Us at BIOCHINA2026 (The 11th EBC Bio-Industry Exhibition)
BIOCHINA2026 (The 11th EBC Bio-Industry Exhibition) will grandly open from March 12-14, 2026 at the Suzhou...
1 2

IP Assurance

At VeloGene, we operate on a strict fee-for-service model. All intellectual property (IP) and materials created for your project are 100% yours. We take every measure to safeguard your IP, ensuring no vectors, ES cells, or mouse lines are retained or resold to third parties. This way, you can focus on your research with complete peace of mind.